Tag Archives: SCHOTT Pharma Strengthens Financial Position as Demand for High-Value Drug Solutions Continues to Rise

SCHOTT Pharma Reports Solid H1 2026 Performance Driven by Strong Demand for Specialized Injectable Solutions

(IN BRIEF) SCHOTT Pharma delivered a resilient performance during the first half of fiscal year 2026, reporting revenue growth despite ongoing market challenges and maintaining strong profitability. The company benefited from continued demand for high-value pharmaceutical containment products, especially sterile … Read the full press release